Eversheds Sutherland advised H2 Equity Partners on €23m acquisition deal

Eversheds Sutherland advised H2 Equity Partners on €23m acquisition deal

Pictured (l-r): James Trevis, Richard Kyle and Elizabeth Tindall

Eversheds Sutherland advised H2 Equity Partners on the acquisition of Aquilant from Dublin-based UDG Healthcare for a potential consideration of up to €23 million.

Aquilant is a distributor of specialist medical, pharmaceutical and scientific products and services, including outsourced sales, marketing, distribution and engineering services to clients in Ireland, the UK and the Netherlands.

The Eversheds Sutherland team was led by James Trevis, Richard Kyle and Elizabeth Tindall in the corporate department.

They received support from across the firm’s English, Dublin and Belfast offices from Thomas Howell and Amy McDermott (corporate), Kathryn Walters, Ben Riding, Piaras Power and Ann Kilbane (banking), Gavin O’Flaherty (corporate), Gareth Planck (real estate), Lisa Bryson (HR), Ben Jones and Colin Askew (tax).

Share icon
Share this article: